Skip to content
2000
Volume 27, Issue 21
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Low aqueous solubility and poor bioavailability are the major hurdles during drug development for the oral route. A large number of the newly discovered drug molecules fall under the BCS II class and have solubility related issues and hence pose low oral bioavailability, which, in turn, render them non-suitable candidates for further development. A multitude of solubility enhancement approaches are available. Notable among them are salt formation, solid dispersions, inclusion complexes, cocrystallization, nanonization, etc. Cocrystallization and nanonization are among the most widely used approaches in the pharmaceutical field that offer multiple enhancements to the active pharmaceutical ingredients. This review endeavours to cover the recent work, important findings, advantages offered by nano-sized cocrystals, future aspects and challenges in the implementation of this newer approach in pharmaceutical research and development.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612826666201112094242
2021-06-01
2025-06-17
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612826666201112094242
Loading

  • Article Type:
    Review Article
Keyword(s): cocrystallization; Cocrystals; nanocrystals; nanomedicine; nanonization; nanotechnology
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test